Enterprise Value
2.836M
Cash
188K
Avg Qtr Burn
-2.23M
Short % of Float
6.73%
Insider Ownership
0.10%
Institutional Own.
1.15%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Prexigebersen (BP1001) Details Acute myeloid leukemia, Cancer | Phase 2 Data readout | |
BP1002 Details Acute myeloid leukemia, Blood cancer, Cancer | Phase 1 Data readout | |
BP1002 Details Lymphoma, Chronic lymphocytic leukemia, Blood cancer, Cancer | Phase 1 Data readout | |
BP1001-A Details Solid tumor/s, Cancer | Phase 1 Data readout |